©2025 Cognivue, Inc. | Privacy Policy | References
Welcome to the Learning Library
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Dr. Galvin connects the dots between breakthrough research and practice, showing how Cognivue Clarity® is designed for real-world clinical workflows.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Highlights how Cognivue Clarity® meets core psychometric criteria, and how normative data can support more precise and equitable cognitive care.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Discusses two research findings that highlight the role of Cognivue Clarity® in detecting cognitive decline associated with underlying Alzheimer’s pathology.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Introduces the Cognivue Amyloid Risk Measure (CARM)—a newly added feature within Cognivue Clarity® that enhances the existing cognitive assessment.
Speakers: Dr. Ruth Morin, Patrick A. Lynch, Dr. Keith Darrow, Dr. Joy Siegel
Tinnitus is more than “ringing in the ears.” It has important connections to cognitive function and emotional well-being.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
A high-level overview of four peer-reviewed publications that highlight the growing clinical utility of Cognivue Clarity®—a validated assessment tool for cognitive.
Speakers: Dr. Keith Darrow, Patrick Lawler, Dr. Joy Siegel
Best practices with screening cognition in hearing care, and how to leverage Cognivue Thrive®—a tool effective in early-stage screening of cognitive changes.
Speaker: Patrick Lawler
“Our mission as a company is to de-stigmatize brain health. This doesn’t have to be scary—we can talk about the brain, and we should talk about the brain.”
Speakers: Dr. Hannah Glick, Dr. Keith Darrow, Dr. Joy Siegel
Explores the hearing loss and cognition connection, and includes best practices on ways to introduce, educate, and integrate cognitive screening.
Speakers: Dr. Sharon Cohen, Dr. Ruth Morin, Dr. Diego Cahn‑Hidalgo, Dr. Ernest Fung
Panelists discuss the importance of primary dementia prevention efforts and the critical role providers play in helping minimize dementia risk
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Dr. Galvin connects the dots between breakthrough research and practice, showing how Cognivue Clarity® is designed for real-world clinical workflows.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Highlights how Cognivue Clarity® meets core psychometric criteria, and how normative data can support more precise and equitable cognitive care.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Discusses two research findings that highlight the role of Cognivue Clarity® in detecting cognitive decline associated with underlying Alzheimer’s pathology.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Introduces the Cognivue Amyloid Risk Measure (CARM)—a newly added feature within Cognivue Clarity® that enhances the existing cognitive assessment.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
A high-level overview of four peer-reviewed publications that highlight the growing clinical utility of Cognivue Clarity®—a validated assessment tool for cognitive.
Speakers: Dr. Sharon Cohen, Dr. Ruth Morin, Dr. Diego Cahn‑Hidalgo, Dr. Ernest Fung
Panelists discuss the importance of primary dementia prevention efforts and the critical role providers play in helping minimize dementia risk
Speakers: Dr. Ruth Morin, Patrick A. Lynch, Dr. Keith Darrow, Dr. Joy Siegel
Tinnitus is more than “ringing in the ears.” It has important connections to cognitive function and emotional well-being.
Speakers: Dr. Keith Darrow, Patrick Lawler, Dr. Joy Siegel
Best practices with screening cognition in hearing care, and how to leverage Cognivue Thrive®—a tool effective in early-stage screening of cognitive changes.
Speaker: Patrick Lawler
“Our mission as a company is to de-stigmatize brain health. This doesn’t have to be scary—we can talk about the brain, and we should talk about the brain.”
Speakers: Dr. Hannah Glick, Dr. Keith Darrow, Dr. Joy Siegel
Explores the hearing loss and cognition connection, and includes best practices on ways to introduce, educate, and integrate cognitive screening.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Dr. Galvin connects the dots between breakthrough research and practice, showing how Cognivue Clarity® is designed for real-world clinical workflows.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Highlights how Cognivue Clarity® meets core psychometric criteria, and how normative data can support more precise and equitable cognitive care.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Discusses two research findings that highlight the role of Cognivue Clarity® in detecting cognitive decline associated with underlying Alzheimer’s pathology.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
Introduces the Cognivue Amyloid Risk Measure (CARM)—a newly added feature within Cognivue Clarity® that enhances the existing cognitive assessment.
Speakers: Dr. James E. Galvin, Dr. Joy Siegel
A high-level overview of four peer-reviewed publications that highlight the growing clinical utility of Cognivue Clarity®—a validated assessment tool for cognitive.













